191 related articles for article (PubMed ID: 30820006)
1. Genotype-Clinical Correlations in Polycystic Kidney Disease with No Apparent Family History.
Sekine A; Fujimaru T; Hoshino J; Suwabe T; Oguro M; Mizuno H; Kawada M; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Mandai S; Chiga M; Kikuchi H; Ando F; Mori T; Sohara E; Uchida S; Sawa N; Takaichi K; Ubara Y
Am J Nephrol; 2019; 49(3):233-240. PubMed ID: 30820006
[TBL] [Abstract][Full Text] [Related]
2. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
Heyer CM; Sundsbak JL; Abebe KZ; Chapman AB; Torres VE; Grantham JJ; Bae KT; Schrier RW; Perrone RD; Braun WE; Steinman TI; Mrug M; Yu AS; Brosnahan G; Hopp K; Irazabal MV; Bennett WM; Flessner MF; Moore CG; Landsittel D; Harris PC;
J Am Soc Nephrol; 2016 Sep; 27(9):2872-84. PubMed ID: 26823553
[TBL] [Abstract][Full Text] [Related]
3. Genetics May Predict Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease.
Sekine A; Hoshino J; Fujimaru T; Suwabe T; Mizuno H; Kawada M; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Mandai S; Chiga M; Kikuchi H; Ando F; Mori T; Sohara E; Uchida S; Sawa N; Takaichi K; Ubara Y
Am J Nephrol; 2020; 51(9):745-751. PubMed ID: 32784291
[TBL] [Abstract][Full Text] [Related]
4. Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial.
Cornec-Le Gall E; Blais JD; Irazabal MV; Devuyst O; Gansevoort RT; Perrone RD; Chapman AB; Czerwiec FS; Ouyang J; Heyer CM; Senum SR; Le Meur Y; Torres VE; Harris PC
Nephrol Dial Transplant; 2018 Apr; 33(4):645-652. PubMed ID: 28992127
[TBL] [Abstract][Full Text] [Related]
5. Interactions between FGF23 and Genotype in Autosomal Dominant Polycystic Kidney Disease.
Grau L; Gitomer B; McNair B; Wolf M; Harris P; Brosnahan G; Torres V; Steinman T; Yu A; Chapman A; Chonchol M; Nowak KL
Kidney360; 2020 Jul; 1(7):648-656. PubMed ID: 33305291
[TBL] [Abstract][Full Text] [Related]
6. PKD1 Truncating Mutations Accelerate eGFR Decline in Autosomal Dominant Polycystic Kidney Disease Patients.
Ali H; Alahmad B; Senum SR; Warsame S; Bahbahani Y; Abu-Farha M; Abubaker J; Alqaddoumi M; Al-Mulla F; Harris PC
Am J Nephrol; 2024; 55(3):380-388. PubMed ID: 38194940
[TBL] [Abstract][Full Text] [Related]
7. Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease.
Chebib FT; Jung Y; Heyer CM; Irazabal MV; Hogan MC; Harris PC; Torres VE; El-Zoghby ZM
Nephrol Dial Transplant; 2016 Jun; 31(6):952-60. PubMed ID: 26932689
[TBL] [Abstract][Full Text] [Related]
8. Effect of tolvaptan on renal involvement in patients with autosomal dominant polycystic kidney disease according to different gene mutations.
Moriyama T; Nakayama Y; Soejima M; Yokota Y; Ota K; Ito S; Kodama G; Nakamura N; Kurokawa Y; Yano J; Ueda U; Takamiya Y; Kaida Y; Hazama T; Shibata R; Koda Y; Fukami K
Clin Exp Nephrol; 2021 Mar; 25(3):251-260. PubMed ID: 33141305
[TBL] [Abstract][Full Text] [Related]
9. Polycystic Kidney Disease without an Apparent Family History.
Iliuta IA; Kalatharan V; Wang K; Cornec-Le Gall E; Conklin J; Pourafkari M; Ting R; Chen C; Borgo AC; He N; Song X; Heyer CM; Senum SR; Hwang YH; Paterson AD; Harris PC; Khalili K; Pei Y
J Am Soc Nephrol; 2017 Sep; 28(9):2768-2776. PubMed ID: 28522688
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive search for mutations in the PKD1 and PKD2 in Japanese subjects with autosomal dominant polycystic kidney disease.
Kurashige M; Hanaoka K; Imamura M; Udagawa T; Kawaguchi Y; Hasegawa T; Hosoya T; Yokoo T; Maeda S
Clin Genet; 2015 Mar; 87(3):266-72. PubMed ID: 24611717
[TBL] [Abstract][Full Text] [Related]
11. Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases.
Higashihara E; Yamamoto K; Kaname S; Okegawa T; Tanbo M; Yamaguchi T; Shigemori K; Miyazaki I; Yokoyama K; Nutahara K
Clin Exp Nephrol; 2019 Jan; 23(1):100-111. PubMed ID: 30097754
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of a consanguineous Iranian polycystic kidney disease family identifies a PKD2 mutation that aids diagnostics.
Vazifehmand R; Rossetti S; Saber S; Khorshid HR; Harris PC
BMC Nephrol; 2013 Sep; 14():190. PubMed ID: 24011172
[TBL] [Abstract][Full Text] [Related]
13. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
Cornec-Le Gall E; Audrézet MP; Renaudineau E; Hourmant M; Charasse C; Michez E; Frouget T; Vigneau C; Dantal J; Siohan P; Longuet H; Gatault P; Ecotière L; Bridoux F; Mandart L; Hanrotel-Saliou C; Stanescu C; Depraetre P; Gie S; Massad M; Kersalé A; Séret G; Augusto JF; Saliou P; Maestri S; Chen JM; Harris PC; Férec C; Le Meur Y
Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
[TBL] [Abstract][Full Text] [Related]
14. Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing.
Kim H; Park HC; Ryu H; Kim H; Lee HS; Heo J; Lee C; Kim NKD; Park WY; Hwang YH; Lee KB; Oh KH; Oh YK; Ahn C
Sci Rep; 2019 Nov; 9(1):16952. PubMed ID: 31740684
[TBL] [Abstract][Full Text] [Related]
15. A potentially crucial role of the PKD1 C-terminal tail in renal prognosis.
Higashihara E; Horie S; Kinoshita M; Harris PC; Okegawa T; Tanbo M; Hara H; Yamaguchi T; Shigemori K; Kawano H; Miyazaki I; Kaname S; Nutahara K
Clin Exp Nephrol; 2018 Apr; 22(2):395-404. PubMed ID: 28983800
[TBL] [Abstract][Full Text] [Related]
16. PKD1-Associated Arachnoid Cysts in Autosomal Dominant Polycystic Kidney Disease.
Shigemori K; Higashihara E; Itoh M; Yoshida H; Yamamoto K; Nutahara K; Shiokawa Y; Kaname S; Tambo M; Yamaguchi T; Taguchi S; Yoshioka T; Yokoyama K; Fukuhara H
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105943. PubMed ID: 34175641
[TBL] [Abstract][Full Text] [Related]
17. Combining genotype with height-adjusted kidney length predicts rapid progression of ADPKD.
Chen EWC; Chong J; Valluru MK; Durkie M; Simms RJ; Harris PC; Ong ACM
Nephrol Dial Transplant; 2024 May; 39(6):956-966. PubMed ID: 38224954
[TBL] [Abstract][Full Text] [Related]
18. Mutational Screening of PKD1 and PKD2 Genes in Iranian Population Diagnosed with Autosomal Dominant Polycystic Kidney Disease.
Ranjzad F; Tara A; Basiri A; Aghdami N; Moghadasali R
Clin Lab; 2017 Jul; 63(7):1261-1267. PubMed ID: 28792715
[TBL] [Abstract][Full Text] [Related]
19. Relationship of Seminal Megavesicles, Prostate Median Cysts, and Genotype in Autosomal Dominant Polycystic Kidney Disease.
Zhang W; Stephens CJ; Blumenfeld JD; Behzadi AH; Donahue S; Bobb WO; Newhouse JH; Rennert H; Zhao Y; Prince MR
J Magn Reson Imaging; 2019 Mar; 49(3):894-903. PubMed ID: 30230107
[TBL] [Abstract][Full Text] [Related]
20. Novel PKD1 and PKD2 mutations in Taiwanese patients with autosomal dominant polycystic kidney disease.
Chang MY; Chen HM; Jenq CC; Lee SY; Chen YM; Tian YC; Chen YC; Hung CC; Fang JT; Yang CW; Wu-Chou YH
J Hum Genet; 2013 Nov; 58(11):720-7. PubMed ID: 23985799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
